Overseas Biocluster Trends
We will share the success stories of overseas bioclusters' R&D allaiances and diagnose the direction of domestic bioclusters.
Learning from global pharmas
Listening from multinational pharmas on what their licensing needs.
Legislation of the new Act on Safety and Support of Advanced Rehabilitation and Advanced Biomedicine, how the policy will change
How the bio pharma policy will change from the implementation of the new law, and point out the future policy direction in which will affect Korea's bio industry.